Product image of Ondansetron Aristo (Ondansetron) supplied by GNH India

Ondansetron Aristo

Active Ingredient:
Ondansetron
Origin:
EU

Ondansetron Aristo (Ondansetron)

Ondansetron, the active ingredient in Ondansetron Aristo, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is employed to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children.

GNH India supplies Ondansetron Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance. The company leverages a robust distribution network to ensure timely delivery across multiple continents and adherence to local import regulations.

Manufacturer / TM Owner

Aristo Pharma Gmbh (Art 57)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron is a selective 5‑HT3 receptor antagonist used to manage nausea and vomiting across several clinical settings.

  • Chemotherapy-induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes in cancer patients.
  • Radiation-induced nausea and vomiting: helps control nausea associated with radiotherapy to the abdomen or pelvis.
  • Postoperative nausea and vomiting: prevents nausea and vomiting after surgical procedures in adults and pediatric patients.

How It Works

  • Ondansetron blocks serotonin (5‑HT3) receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By inhibiting these receptors, it interrupts the neural signaling that initiates the vomiting reflex, thereby providing antiemetic protection during chemotherapy, radiation, and surgery.

Side Effects

Common Side Effects

  • Headache: mild to moderate pain often reported.
  • Constipation: reduced bowel movements.
  • Diarrhoea: loose stools.
  • Fatigue: feeling of tiredness.
  • Dizziness: light‑headed sensation.
  • Abdominal discomfort: mild stomach pain.

Serious or Rare Side Effects

  • QT prolongation: may lead to cardiac arrhythmias.
  • Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty.
  • Serotonin syndrome: rare when combined with other serotonergic drugs.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Cardiac arrhythmia: irregular heart rhythm beyond QT issues.

Precautions & Warnings

Precautions should be observed before initiating therapy.

  • Cardiac assessment: evaluate ECG in patients with known QT prolongation.
  • Concomitant medications: avoid or monitor drugs that also prolong QT interval.
  • Hepatic impairment: use with caution and consider dose adjustment.
  • Pregnancy and lactation: prescribe only if benefit outweighs potential risk.
  • Allergic reactions: discontinue immediately if signs of severe hypersensitivity appear.
  • Store at room temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Avoid Interactions

Ondansetron may interact with several medicines.

Major Interactions (Avoid)

  • Apomorphine: can cause severe hypotension.
  • Certain antiarrhythmics (e.g., amiodarone): increase risk of QT prolongation.
  • Other 5‑HT3 antagonists: no additive benefit and may raise plasma levels.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron concentrations.
  • CYP3A4 inducers (e.g., rifampin): may reduce effectiveness.
  • Anticholinergic agents: may exacerbate constipation.
  • Opioids: heightened risk of constipation.
  • Serotonergic antidepressants: monitor for serotonin syndrome.

Frequently Asked Questions

Ondansetron Aristo is an antiemetic tablet used to prevent and treat nausea and vomiting that can occur after chemotherapy, radiation therapy, or surgical procedures. It is prescribed for both adult and pediatric patients when these treatments are expected to cause emesis.

Ondansetron works by selectively blocking serotonin 5‑HT3 receptors in the gastrointestinal tract and the brain's chemoreceptor trigger zone. This inhibition stops the neural signals that trigger the vomiting reflex, providing relief from nausea associated with cancer therapy and surgery.

The specific dose of Ondansetron Aristo is determined by the prescribing clinician based on the indication, patient age, weight, renal and hepatic function, and the timing of chemotherapy or surgery. The prescriber sets the appropriate regimen for each individual case.

Safety data for ondansetron in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit justifies the possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Compared with dopamine antagonists, ondansetron offers targeted 5‑HT3 blockade, resulting in fewer extrapyramidal side effects while maintaining similar efficacy for acute nausea. It is often preferred for chemotherapy‑induced emesis due to its specific mechanism and tolerability profile.

Store the tablets at room temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct light, and avoid exposure to extreme temperatures to preserve potency.

Ondansetron Aristo tablets are taken orally, with or without food, as directed by the prescriber. The timing relative to chemotherapy, radiation, or surgery is specified in the treatment plan to achieve optimal antiemetic effect.

Serious risks include QT interval prolongation that can lead to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and rare cases of serotonin syndrome when combined with other serotonergic agents. Patients should be monitored for these events.

Individuals with known hypersensitivity to ondansetron or any excipients, patients with congenital long QT syndrome, and those taking other medications that significantly prolong the QT interval should avoid using Ondansetron Aristo unless advised otherwise by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT